Efficacy and Safety Aiming at the Combined-Modality Therapy of External Beam Radiotherapy (40Gy) and Iodine-125 Seed Implantation for Locally Advanced NSCLC in the Elderly

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.28055103
   PubMed Web of Science ®Google Scholar
• Wu C, Li B, Sun G, Peng C, Xiang D. Efficacy and safety of iodine-125 brachytherapy combined with chemotherapy in the treatment of advanced NSCLC in the elderly. Onco Targets Ther. 2018;11:6617–6624. doi:10.2147/OTT.S17445730349295
   PubMed Web of Science ®Google Scholar
• Toschi L, Rossi S, Finocchiaro G, Santoro A. Non-small cell lung cancer treatment (r)evolution: ten years of advances and more to come. Ecancermedicalscience. 2017;11:787. doi:10.3332/ecancer.2017.78729225694
   PubMed Web of Science ®Google Scholar
• Rong B, Zhao C, Gao W, Yang S. Matrine promotes the efficacy and safety of platinum-based doublet chemotherapy for advanced non-small cell lung cancer. Int J Clin Exp Med. 2015;8(9):14701–14717.26628952
   PubMed Web of Science ®Google Scholar
• Reveiz L, Rueda JR, Cardona AF. Palliative endobronchial brachytherapy for non-small cell lung cancer. Cochrane Database Syst Rev. 2012;12:CD004284.23235606
   PubMed Web of Science ®Google Scholar
• Ozcan MF, Altinova S, Atan A. Treatment approaches to small renal masses in patients of advanced age (>/=75 years). Turk J Urol. 2018;44(4):281–286. doi:10.5152/tud.2018.0482929932396
   PubMed Web of Science ®Google Scholar
• Xiang GL, Zhu XH, Lin CZ, et al. 125I seed irradiation induces apoptosis and inhibits angiogenesis by decreasing HIF-1alpha and VEGF expression in lung carcinoma xenografts. Oncol Rep. 2017;37(5):3075–3083. doi:10.3892/or.2017.552128339070
   PubMed Web of Science ®Google Scholar
• Cheng J, Ma S, Yang G, Wang L, Hou W. The Mechanism of Computed Tomography-Guided 125I Particle in Treating Lung Cancer. Med Sci Monit. 2017;23:292–299. doi:10.12659/MSM.89852628095393
   PubMed Web of Science ®Google Scholar
• Ji Z, Jiang Y, Guo F, et al. Safety and efficacy of CT-guided radioactive iodine-125 seed implantation assisted by a 3D printing template for the treatment of thoracic malignancies. J Cancer Res Clin Oncol. 2020;146(1):229–236. doi:10.1007/s00432-019-03050-731630263
   PubMed Web of Science ®Google Scholar
• Di Maio M, Perrone F. Quality of Life in elderly patients with cancer. Health Qual Life Outcomes. 2003;1:44. doi:10.1186/1477-7525-1-4414525617
   PubMedGoogle Scholar
• Dai F, Wang J, An H, et al. Therapy of (125)I particles implantation inhibited the local growth of advanced non-small cell lung cancer: a retrospective clinical study. Am J Transl Res. 2019;11(6):3737–3749.31312384
   PubMed Web of Science ®Google Scholar
• Skowronek J. Brachytherapy in the treatment of lung cancer - a valuable solution. J Contemp Brachytherapy. 2015;7(4):297–311. doi:10.5114/jcb.2015.5403826622233
   PubMed Web of Science ®Google Scholar
• Qiu H, Ji J, Shao Z, et al. The Efficacy and Safety of Iodine-125 Brachytherapy Combined with Chemotherapy in Treatment of Advanced Lung Cancer: a Meta-Analysis. J Coll Physicians Surg Pak. 2017;27(4):237–245.28492154
   PubMed Web of Science ®Google Scholar
• Huo X, Huo B, Wang H, et al. Implantation of computed tomography-guided Iodine-125 seeds in combination with chemotherapy for the treatment of stage III non-small cell lung cancer. J Contemp Brachytherapy. 2017;9(6):527–534. doi:10.5114/jcb.2017.7260529441096
   PubMed Web of Science ®Google Scholar
• Chen Y, Li Y, Jia Y, et al. Bronchial artery chemoembolization combined with radioactive iodine-125 seed implantation in the treatment of advanced nonsmall cell lung cancer. J Cancer Res Ther. 2017;13(4):636–641. doi:10.4103/jcrt.JCRT_93_1728901306
   PubMed Web of Science ®Google Scholar
• Li W, Dan G, Jiang J, Zheng Y, Zheng X, Deng D. Repeated iodine-125 seed implantations combined with external beam radiotherapy for the treatment of locally recurrent or metastatic stage III/IV non-small cell lung cancer: a retrospective study. Radiat Oncol. 2016;11(1):119. doi:10.1186/s13014-016-0688-527623620
   PubMed Web of Science ®Google Scholar
• Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–1474. doi:10.1245/s10434-010-0985-420180029
   PubMed Web of Science ®Google Scholar
• de Kock I, Mirhosseini M, Lau F, et al. Conversion of Karnofsky Performance Status (KPS) and Eastern Cooperative Oncology Group Performance Status (ECOG) to Palliative Performance Scale (PPS), and the interchangeability of PPS and KPS in prognostic tools. J Palliat Care. 2013;29(3):163–169. doi:10.1177/08258597130290030524380215
   PubMed Web of Science ®Google Scholar
• Stewart A, Parashar B, Patel M, et al. American Brachytherapy Society consensus guidelines for thoracic brachytherapy for lung cancer. Brachytherapy. 2016;15(1):1–11. doi:10.1016/j.brachy.2015.09.00626561277
   PubMed Web of Science ®Google Scholar
• Watanabe H, Okada M, Kaji Y, et al. [New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)]. Gan to Kagaku Ryoho. 2009;36(13):2495–2501. [Japanese].20009446
   PubMedGoogle Scholar
• Licqurish SM, Cook OY, Pattuwage LP, et al. Tools to facilitate communication during physician-patient consultations in cancer care: an overview of systematic reviews. CA Cancer J Clin. 2019;69(6):497–520. doi:10.3322/caac.2157331339560
   PubMed Web of Science ®Google Scholar
• Matsuoka H, Nishio W, Okada M, Sakamoto T, Yoshimura M, Tsubota N. Resection of chest wall invasion in patients with non-small cell lung cancer. Eur J Cardiothorac Surg. 2004;26(6):1200–1204. doi:10.1016/j.ejcts.2004.07.03815541985
   PubMed Web of Science ®Google Scholar
• Curran WJ, Paulus R, Langer CJ, et al. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized Phase III trial RTOG 9410. J Natl Cancer Inst. 2011;103(19):1452–1460. doi:10.1093/jnci/djr32521903745
   PubMedGoogle Scholar
• Li W, Guan J, Yang L, Zheng X, Yu Y, Jiang J. Iodine-125 brachytherapy improved overall survival of patients with inoperable stage III/IV non-small cell lung cancer versus the conventional radiotherapy. Med Oncol. 2015;32(1):395. doi:10.1007/s12032-014-0395-825428394
   PubMed Web of Science ®Google Scholar
• Yu H, Wu H, Wang W, et al. Machine learning to build and validate a model for radiation pneumonitis prediction in patients with non-small cell lung cancer. Clin Cancer Res. 2019;25(14):4343–4350. doi:10.1158/1078-0432.CCR-18-108430992302
   PubMed Web of Science ®Google Scholar
• Gridelli C, Perrone F, Gallo C, et al. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the multicenter Italian lung cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst. 2003;95(5):362–372. doi:10.1093/jnci/95.5.36212618501
   PubMed Web of Science ®Google Scholar
• Lanuti M. Surgical management of lung cancer involving the chest wall. Thorac Surg Clin. 2017;27(2):195–199. doi:10.1016/j.thorsurg.2017.01.01328363374
   PubMed Web of Science ®Google Scholar
• Powell JW, Dexter E, Scalzetti EM, Bogart JA. Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials. Lancet Oncol. 2009;10(9):885–894. doi:10.1016/S1470-2045(09)70103-219717090
   PubMed Web of Science ®Google Scholar
• Doddoli C, D’Journo B, Le Pimpec-barthes F, et al. Lung cancer invading the chest wall: a plea for en-bloc resection but the need for new treatment strategies. Ann Thorac Surg. 2005;80(6):2032–2040. doi:10.1016/j.athoracsur.2005.03.08816305839
   PubMed Web of Science ®Google Scholar
• Nagata Y, Wulf J, Lax I, et al. Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys. 2011;79(3):660–669. doi:10.1016/j.ijrobp.2010.10.00421281896
   PubMed Web of Science ®Google Scholar
• Huang Q, Chen J, Chen Q, et al. Computed tomographic-guided iodine-125 interstitial implants for malignant thoracic tumors. Eur J Radiol. 2013;82(11):2061–2066. doi:10.1016/j.ejrad.2013.05.03723830205
   PubMed Web of Science ®Google Scholar
• Pan H, Shen P, Shu Q, et al. Efficacy and safety of sustained-release oxycodone compared with immediate-release morphine for pain titration in cancer patients: a multicenter, open-label, randomized controlled trial (SOCIAL). Medicine (Baltimore). 2019;98(24):e15505. doi:10.1097/MD.000000000001550531192908
   PubMed Web of Science ®Google Scholar
• Song J, Fan X, Zhao Z, et al. (125)I brachytherapy of locally advanced non-small-cell lung cancer after one cycle of first-line chemotherapy: a comparison with best supportive care. Onco Targets Ther. 2017;10:1345–1352. doi:10.2147/OTT.S12990328280369
   PubMed Web of Science ®Google Scholar
• Jiang Y, Ji Z, Guo F, et al. Side effects of CT-guided implantation of (125)I seeds for recurrent malignant tumors of the head and neck assisted by 3D printing non co-planar template. Radiat Oncol. 2018;13(1):18. doi:10.1186/s13014-018-0959-429394937
   PubMed Web of Science ®Google Scholar
• Barriger RB, Fakiris AJ, Hanna N, Yu M, Mantravadi P, McGarry RC. Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel. Int J Radiat Oncol Biol Phys. 2010;78(5):1381–1386. doi:10.1016/j.ijrobp.2009.09.03020231061
   PubMed Web of Science ®Google Scholar
• Phernambucq EC, Spoelstra FO, Verbakel WF, et al. Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity. Ann Oncol. 2011;22(1):132–138. doi:10.1093/annonc/mdq31620595452
   PubMed Web of Science ®Google Scholar
• Werner-Wasik M, Paulus R, Curran WJ, Byhardt R. Acute esophagitis and late lung toxicity in concurrent chemoradiotherapy trials in patients with locally advanced non-small-cell lung cancer: analysis of the radiation therapy oncology group (RTOG) database. Clin Lung Cancer. 2011;12(4):245–251. doi:10.1016/j.cllc.2011.03.02621726824
   PubMed Web of Science ®Google Scholar